Cardiometabolic diseases encompass those affecting the heart and vasculature as well as
other metabolic problems, such as insulin resistance, diabetes, and non-alcoholic fatty liver …

Adiponectin is an abundant plasma protein secreted from adipocytes. Its role in energy
homeostasis is well-known, including the regulation of hydrocarbons and lipids metabolism …

Metabolic cardiovascular diseases have become a global health concern, and some of their
risk factors are linked to several metabolic disorders. They are the leading causes of death …

Cardiovascular disease (CVD) is the leading cause of death worldwide and the prevalence
of obesity and diabetes are increasing. In obesity, adipose tissue increases the secretion of …

The global epidemic of obesity is accompanied by an increased prevalence of
cardiovascular disease (CVD), in particular stroke and heart attack. Dysfunctional adipose …

Background: Adiponectin is an adipocyte-derived cytokine closely associated with obesity,
altered body adipose tissue distribution, insulin resistance, and cardiovascular diseases …

In obesity, the expansion of dysfunctional adipose tissue leads to augmented production of
pro-inflammatory adipokines that mediate metabolic changes through their paracrine and/or …

Adiponectin is a secretory protein predominantly expressed by adipocytes and released at a
high rate into circulation. The ease with which the levels of adiponectin can be measured …

Adiponectin is produced predominantly by adipocytes and plays an important role in
metabolic and cardiovascular homeostasis through its insulin-sensitizing actions and anti …

Adiponectin, an adipokine that circulates as multiple multimeric complexes at high levels in
serum, has antidiabetic, anti-inflammatory, antiatherogenic, and cardioprotective properties …